Latest Headlines

Latest Headlines

India's Lupin buys Brazil's Medquimica as part of M&A growth plan

Continuing to spread its wings, India's Lupin now has a toehold in the Brazil market by buying Medquímica Indústria Farmacêutica, producer of branded, generic and over-the-counter drugs.

From the pharma C-suite: Notable, quotable remarks on Asia, emerging markets for Q1 (Part 5)

FiercePharmaAsia  combs earnings calls by major drug companies for notable and quotable nuggets on emerging markets and Asia to track the latest sales trends and insight into business outlooks in markets as diverse as China, India and Japan to Southeast Asia.

Catalent buys up Brazilian CMO with eye on growing market

Catalent has snapped up a Brazilian contract manufacturer, expanding its hold on the global softgel market by growing its presence in Latin America.

China, low-cost markets lead future eClinical tech growth

Providers of clinical trials tech have sought overseas partnerships as emerging and low-cost markets play larger roles in drug and device development. With more clinical trials outsourced overseas, according to a new study, China and the rest of Asia-Pacific territories, Latin America, the Middle East and Africa are expected to be the fastest-growing markets for eClinical technology.

DSM expands CMO biz with first Brazilian deal

DSM Pharmaceutical Products, the CMO wing of Royal DSM, has signed a deal to manufacture biologics for Brazil's Recepta Biopharma.

Quintiles expands to Brazil, eyeing $17B biopharma market

Quintiles is expanding its sales reach to Brazil, opening up an arm of its commercial solutions business to tap into that country's growing pharma market.

Brazil's FBM Industria licenses Ampio's quick-dissolve premature-ejaculation pill

Ampio Pharmaceuticals is taking steps to get its premature-ejaculation drug on the market around the world.

Study: Brazil bests India for subject recruitment

Sponsors looking for clinical trial volunteers are better off heading south rather than east. Using systematic review and meta-analysis of data on people's willingness to participate in clinical

Brazil to join ranks of Gaucher's drug makers

In a shot across Genzyme's damaged bow, Protalix and Pfizer are aligning with Brazil in a licensing deal for taliglucerase alfa, a treatment for Gaucher's disease. The Brazilian health minister says

GE Healthcare opens first South American factory

GE Healthcare has opened its first factory in South America, in the town of Contagem, Brazil. With a planned investment of $50 million over a 10-year period, the company is committed to the